Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Sinclair

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of the International AIDS Society|September 13, 2022
Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness studyCindy P Garris, Maggie Czarnogorski, Marybeth Dalessandro, et al.
Journal of the International AIDS Society|September 12, 2022
Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE)Maggie Czarnogorski, Cindy P Garris, Marybeth Dalessandro, et al.
Contemporary Clinical Trials|November 11, 2025
Analytical treatment interruption as a tool in the evaluation of immune-mediated interventions for long-term antiretroviral-free control of HIV-1 among people with HIVAna Gabriela Pires Dos Santos, Manal Abunimeh, Beatriz Mothe, et al.
Journal of Clinical Pathology|August 29, 2006
Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatmentsJ R Kerr, P Christian, A Hodgetts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differencesE Keats Shwab, Gita A Pathak, Joshua Harvey, et al.
The Journal of Infectious Diseases|May 9, 2008
Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitisJonathan R Kerr, Robert Petty, Beverley Burke, et al.
The New England Journal of Medicine|May 11, 2022
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 InfectionSorana Segal-Maurer, Edwin DeJesus, Hans-Jurgen Stellbrink, et al.
Data in Brief|December 8, 2021
A synchrotron computed tomography dataset for validation of longitudinal tensile failure models based on fibre break and cluster developmentC Breite, A Melnikov, A Turon, et al.
Annals of Internal Medicine|December 22, 2025
Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized StudyAmy E Colson, Gordon E Crofoot, Peter J Ruane, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsDylan X Guan, Byron Creese, Cassandra M Germain, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of the International AIDS Society|September 13, 2022
Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness studyCindy P Garris, Maggie Czarnogorski, Marybeth Dalessandro, et al.
Journal of the International AIDS Society|September 12, 2022
Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE)Maggie Czarnogorski, Cindy P Garris, Marybeth Dalessandro, et al.
Contemporary Clinical Trials|November 11, 2025
Analytical treatment interruption as a tool in the evaluation of immune-mediated interventions for long-term antiretroviral-free control of HIV-1 among people with HIVAna Gabriela Pires Dos Santos, Manal Abunimeh, Beatriz Mothe, et al.
Journal of Clinical Pathology|August 29, 2006
Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatmentsJ R Kerr, P Christian, A Hodgetts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differencesE Keats Shwab, Gita A Pathak, Joshua Harvey, et al.
The Journal of Infectious Diseases|May 9, 2008
Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitisJonathan R Kerr, Robert Petty, Beverley Burke, et al.
The New England Journal of Medicine|May 11, 2022
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 InfectionSorana Segal-Maurer, Edwin DeJesus, Hans-Jurgen Stellbrink, et al.
Data in Brief|December 8, 2021
A synchrotron computed tomography dataset for validation of longitudinal tensile failure models based on fibre break and cluster developmentC Breite, A Melnikov, A Turon, et al.
Annals of Internal Medicine|December 22, 2025
Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized StudyAmy E Colson, Gordon E Crofoot, Peter J Ruane, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsDylan X Guan, Byron Creese, Cassandra M Germain, et al.
Pageof 12